Biggest News Aggregation in the World
📰 Sunset Yellow News

Page 2 - Sunset Yellow News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Sunset Yellow. Real-time updates on events, politics, business and more.

Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colo

− FRUZAQLA is the First Targeted Therapy Approved for Metastatic Colorectal Cancer (mCRC) Regardless of Biomarker Status or Prior Types of Therapies in More Than a Decade− FRUZAQLA Plus Best Supportive Care Demonstrated Significant Improvements in Overall Survival, with Corresponding Improvements in Progression Free...
United States Al Qahirah Hong Kong Cancer Institute Cathy Eng Jun Saito

Takeda Receives U.S. FDA Approval of FRUZAQLA fruquintinib for Previously Treated Metastatic Colorectal Cancer

Takeda TSE4502NYSETAK today announced that the U.S. Food and Drug Administration FDA has approved FRUZAQLA fruquintinib an oral targeted therapy for adults with metastatic colorectal cancer mCRC who have been previously treated with fluoropyrimidine oxaliplatin and irinotecanbased chemotherapy an antiVEGF therapy and if RAS wildtype and medically appropriate an antiEGFR therapy.
Al Qahirah Hong Kong Cancer Institute United States Gastroenterol Hepatol Jun Saito

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancer

OSAKA, Japan & CAMBRIDGE, Mass., November 08, 2023--Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved FRUZAQLA™ (fruquintinib), an oral targeted therapy for adults with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy. FRUZAQLA is the first and onl...
United States Al Qahirah Cancer Institute Hong Kong Ahcene Djaballah Gastroenterol Hepatol
Source: yahoo.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science